HealthEquity (NASDAQ:HQY) PT Lowered to $100.00 at Bank of America

HealthEquity (NASDAQ:HQY) had its price target cut by Bank of America from $105.00 to $100.00 in a research report sent to investors on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock.

HQY has been the subject of several other reports. Royal Bank of Canada reaffirmed an outperform rating and set a $92.00 price objective on shares of HealthEquity in a report on Tuesday, June 4th. Robert W. Baird upped their price objective on shares of HealthEquity from $98.00 to $104.00 and gave the stock an outperform rating in a report on Tuesday, June 4th. Wells Fargo & Company upped their price objective on shares of HealthEquity from $107.00 to $110.00 and gave the stock an overweight rating in a report on Thursday, June 20th. KeyCorp upped their price objective on shares of HealthEquity from $95.00 to $100.00 and gave the stock an overweight rating in a report on Wednesday, June 5th. Finally, JMP Securities upped their price objective on shares of HealthEquity from $101.00 to $105.00 and gave the stock a market outperform rating in a report on Tuesday, June 4th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, HealthEquity presently has an average rating of Moderate Buy and a consensus price target of $103.83.

HealthEquity Stock Performance

HQY stock opened at $76.24 on Wednesday. The company has a quick ratio of 4.39, a current ratio of 4.39 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $6.63 billion, a price-to-earnings ratio of 82.87, a P/E/G ratio of 1.34 and a beta of 0.52. HealthEquity has a 12 month low of $61.81 and a 12 month high of $88.26. The firm has a 50 day moving average of $77.03 and a two-hundred day moving average of $79.67.

Insider Activity

In other news, CEO Jon Kessler sold 32,326 shares of the stock in a transaction on Monday, June 24th. The shares were sold at an average price of $82.83, for a total value of $2,677,562.58. Following the completion of the transaction, the chief executive officer now owns 232,176 shares in the company, valued at approximately $19,231,138.08. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, CEO Jon Kessler sold 32,326 shares of the stock in a transaction on Monday, June 24th. The shares were sold at an average price of $82.83, for a total value of $2,677,562.58. Following the completion of the transaction, the chief executive officer now owns 232,176 shares in the company, valued at approximately $19,231,138.08. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of the company’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the completion of the sale, the insider now directly owns 89,769 shares in the company, valued at approximately $7,168,952.34. The disclosure for this sale can be found here. In the last 90 days, insiders sold 75,031 shares of company stock worth $6,103,625. 2.20% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On HealthEquity

Several large investors have recently made changes to their positions in the company. Brown Financial Advisors bought a new stake in shares of HealthEquity in the 2nd quarter worth about $331,000. Clearbridge Investments LLC grew its holdings in shares of HealthEquity by 1.9% in the 2nd quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company’s stock worth $204,915,000 after purchasing an additional 43,491 shares during the last quarter. Truist Financial Corp grew its holdings in shares of HealthEquity by 7.0% in the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock worth $247,000 after purchasing an additional 188 shares during the last quarter. Chase Investment Counsel Corp grew its holdings in shares of HealthEquity by 19.1% in the 2nd quarter. Chase Investment Counsel Corp now owns 40,986 shares of the company’s stock worth $3,532,000 after purchasing an additional 6,572 shares during the last quarter. Finally, Creative Planning grew its holdings in HealthEquity by 25.0% during the 2nd quarter. Creative Planning now owns 19,926 shares of the company’s stock worth $1,718,000 after acquiring an additional 3,983 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.